Skip to content
Search

Latest Stories

Holland & Barrett joins PAGB as retailer regulatory member

Holland & Barrett joins PAGB as retailer regulatory member

As part of PAGB, Holland & Barrett gains access to expert guidance and support on regulatory matters

Holland & Barrett, the UK’s leading wellness retailer, has become the latest retailer regulatory member of PAGB, the consumer healthcare association.


PAGB represents the manufacturers of branded over-the-counter (OTC) medicines, self care medical devices and food supplements in the UK.

Holland & Barrett's decision to PAGB follows its recent introduction of a selected range of OTC and healthcare products in its stores across the UK. These include painkillers, cough and cold medicines, children’s health essentials, hay fever relief, as well as skin and gastrointestinal products.

With this expansion, the retailer aims to not only help customers to stay well, but also provide relief when needed.

As part of PAGB, Holland & Barrett gains access to expert guidance and support on regulatory matters.

Commenting on the partnership, John Miller, Group Technical & Sourcing Director - International at Holland & Barrett, said: “At Holland & Barrett we have a long-standing history in the wellness space, backed by our own research, data and insights, and we’re continually striving to ensure that our consumer healthcare offer represents best practice.

“PAGB’s expert guidance and support in the sector will be invaluable in helping us to keep ahead of the evolving regulatory landscape.”

Michelle Riddalls, CEO at PAGB, welcomed Holland & Barrett's membership, emphasising the company's esteemed reputation in health, wellness, and self-care in the UK.

She noted that PAGB is eager to collaborate with Holland & Barrett to “amplify the impact of their business and their voice in the consumer healthcare sector.”

“We’re pleased also to be able to provide our expert advice and guidance to support Holland & Barrett with self-regulation, in addition to advocating on behalf of the industry through our work influencing government and policy and promoting self-care,” she added.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less